Maackiain Reduces Neuroinflammation by Modulating Inflammatory Signals in LPS-Induced <i>In Vitro</i> and <i>In Vivo</i> Models.

J Microbiol Biotechnol · 2026 · PMC12883318 · PMID 41645538

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Compared to the Control group, the 10 μM MAA treatment group already exhibited a decreasing trend in ROS levels, while the 20 μM group showed more pronounced inhibitory effects.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Maackiain Reduces Neuroinflammation by Modulating Inflammatory Signals in LPS-Induced &lt;i&gt;In Vitro&lt;/i&gt; and &lt;i&gt;In Vivo&lt;/i&gt; Models.

The sentences

Maackiain Reduces Neuroinflammation by Modulating Inflammatory Signals in LPS-Induced <i>In Vitro</i> and <i>In Vivo</i> Models.